anti-obesity medicine
Scope
Date
~
-
Bio & Pharma
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...
Jan 04, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Jan 01, 2024 (Gmt+09:00)
-
Aerospace & Defense
Hanwha wins S.Korean military anti-drone system deals
South Korean aerospace and defense maker Hanwha Systems Co. is set to establish a military system to cope with small unmanned aerial vehicles (UAVs)...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HD Hyundai builds Aegis destroyer with anti-ballistic missiles
ULSAN, South Korea – At the shipyard of HD Hyundai Heavy Industries Co. on Nov. 20 in Ulsan, South Gyeongsang Province, South Korea's ne...
Nov 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets FDA OK for its interchangeable biosimilar
Byooviz, a biosimilar of the macular degeneration treatment Lucentis and made by South Korea’s Samsung Bioepis, has received official design...
Oct 25, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Regulations
Korea’s antitrust body grants conditional OK to Broadcom-VMware deal
South Korea’s antitrust regulator on Monday granted conditional approval for US smartphone components maker Broadcom Inc.’s proposed pur...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's GER drug gets product OK from Mexico
South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...
Oct 19, 2023 (Gmt+09:00)
-
The KED View
Five most common frustrations of Korean entrepreneurs
A South Korean company recently gave up on its plan to venture into the burgeoning robot market.Fair-trade regulations that prohibit the creation of...
Oct 12, 2023 (Gmt+09:00)
-
Korean food
Gluten-free Korean snack, pea soy sauce lure European gourmets
COLOGNE, Germany – The traditional Korean snack yakgwa and a soy-like sauce made with peas were named innovative foods of the year at the worl...
Oct 10, 2023 (Gmt+09:00)
-
Steel
Japanese steelmakers flood South Korea on back of weaker yen
Japanese steelmakers are expanding their market shares in South Korea, backed by the yen's drop against the Korean won to the lowest in eight years....
Sep 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Moderna signs mRNA access deals with S.Korea's universities
The US biotech and pharmaceutical company Moderna on Friday announced signings of contracts with the academic-industry cooperation foundations of Ko...
Sep 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Science joins race to develop Wegovy competitor
Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...
Sep 13, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
S.Korean food company hy boosts cosmetics unit
South Korea’s hy, formerly Korea Yakult, has launched cosmetics made with fermented products using its self-developed lactic acid bacteria, ex...
Sep 07, 2023 (Gmt+09:00)
-
Aerospace & Defense
LIG Nex1 participates in drone road show in Riyadh
South Korean leading defense company LIG Nex1 Co. took part in a drone-focused workshop "2023 Korea-Saudi Arabia Drone Road Show" in Riyadh, Saudi A...
Aug 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on prescription of 10 private US insurers
South Korea’s Celltrion Healthcare Co. announced on Wednesday that it has signed contracts with 10 insurance providers in the US to boost the ...
Aug 23, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Qurient, US National Cancer Institute to develop anti-cancer drug
South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...
Aug 14, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience buys 6.5 million Novavax shares for $83.4 million
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...
Aug 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung Pharma's sales surpass $311 mn in H1 2023
South Korea’s Boryung Corp. has alleviated the fear of falling behind in its sector expressed by its third-generation chairman Jay Kim Jung-Gy...
Jul 28, 2023 (Gmt+09:00)
-
Logistics
CJ Logistics to enter global pharmaceutical transportation market
South Korea’s CJ Logistics on Wednesday said it obtained the certification CEIV Pharma, or the Center of Excellence for Independent Validators...
Jul 26, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals gets OK to sell epilepsy drug in Canada
South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...
Jul 12, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hyundai Wia completes flying drone interception test
Hyundai Wia Corp., an auto parts and defense unit of Hyundai Motor Group, announced on Thursday that the first shooting trial of its anti-drone syst...
Jul 06, 2023 (Gmt+09:00)
-
Bio & Pharma
SCM Lifescience kicks off anti-hair loss product exports to SE Asia
South Korea’s stem cell tech company SCM Lifescience on Wednesday said it has started full-scale exports to Southeast Asia of its hair loss ca...
Jul 06, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Blackstone seeks medicine distributor sale for 1st Korea exit
Blackstone Inc. has embarked on the process of selling South Korea’s largest medicine wholesaler Geo-Young Corp., a deal estimated at up to $1...
Jul 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $897 mn in two deals with Pfizer
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of production capacity, said on Tuesday it has w...
Jul 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand